LUMAKRAS

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: 68c7b547fd14f2c5
Drug Approval Canada Name: LUMAKRAS
Product Name: LUMAKRAS
Status: Marketed
Status Date: 2021-10-22
Original Market Date: 2021-10-22
Din: 02520095
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XX73 SOTORASIB
Atc Name: l 01 xx 73
Aig Number: 0163153001
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

SOTORASIB

120 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

68c7b547fd14f2c5

Type

Standard